Identifying and validating biomarkers for Alzheimer's disease

Humpel, Christian·2011·Trends in Biotechnology

Cited by (484)

Items 201–300 of 484

  1. Novel combinations of phenotypic biomarkers predict development of epilepsy in the lithium–pilocarpine model of temporal lobe epilepsy in rats
    Sonja Bröer, Wolfgang Löscher · 2015 · Epilepsy & Behavior
  2. Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients
    Rinko Grewal, Mona Haghighi, Shuai Huang, Amanda Smith, Chuanhai Cao, Xiaoyang Lin, Daniel C. Lee, Nancy Teten, Angela M. Hill, Maj‐Linda B. Selenica · 2016 · Alzheimer s Research & Therapy
  3. Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer’s Disease as Identified by Targeted Metabolomics
    Josef Marksteiner, Herbert Oberacher, Christian Humpel · 2019 · Journal of Alzheimer s Disease
  4. A circular RNA blood panel that differentiates Alzheimer’s disease from other dementia types
    Ziye Ren, Changbiao Chu, Yana Pang, Huimin Cai, Longfei Jia · 2022 · Biomarker Research
  5. Platelet-Derived Secreted Amyloid-Precursor Protein-β as a Marker for Diagnosing Alzheimer’s Disease
    Josef Marksteiner, Christian Humpel · 2013 · Current Neurovascular Research
  6. Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?
    Herbert Oberacher, Kathrin Arnhard, Caroline Linhart, Angela Diwo, Josef Marksteiner, Christian Humpel · 2017 · Journal of Alzheimer s Disease
  7. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer’s Disease
    Stephanie M. Williams, Philip Schulz, Terrone L. Rosenberry, Richard J. Caselli, Michael R. Sierks · 2017 · Journal of Alzheimer s Disease
  8. Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease
    Santos, Joana R. F., Bauer, Chris, Schuchhardt, Johannes, Wedekind, Dirk, Waniek, Katharina, Lachmann, Ingolf, Wiltfang, Jens, Vogelgsang, Jonathan · 2019 · Journal of Neural Transmission
  9. Multiple capillary isotachophoresis with repetitive hydrodynamic injections for performance improvement of the electromigration preconcentration
    Thanh Duc Mai, Farid Oukacine, Myriam Taverna · 2016 · Journal of Chromatography A
  10. Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease
    Imrich Blasko, Michaela Defrancesco, Herbert Oberacher, Lorin Loacker, Georg Kemmler, Josef Marksteiner, Christian Humpel · 2021 · Experimental Gerontology
  11. Diagnosing Alzheimer’s disease: are we any nearer to useful biomarker-based, non-invasive tests?
    Lydia C B Fletcher, Katie E Burke, Paul Caine, Natasha Rinne, Charlotte A Braniff, Hannah Davis, Kathryn Miles, Claire Packer · 2013 · Europe PMC (PubMed Central)
  12. Plasma lipids metabolism in mild cognitive impairment and Alzheimer’s disease
    Alana C. Costa, Helena Passarelli Giroud Joaquim, Orestes Vicente Forlenza, Leda Leme Talib, Wagner F. Gattaz · 2017 · The World Journal of Biological Psychiatry
  13. More than a drainage fluid: the role of CSF in signaling in the brain and other effects on brain tissue
    Sebastian Illes · 2017 · Handbook of clinical neurology
  14. Protective Role Of Apigenin Against Aβ25-35 Toxicity Via Inhibition Of Mitochondrial Cytochrome C Release
    Farnaz Nikbakht, Yasaman Khadem, Sobhan Haghani, Hadiseh Hoseininia, Moein Sadat Alireza, Paria Hashemi, Nida Jamali · 2019 · Basic and Clinical Neuroscience Journal
  15. Integrating music‐based interventions with Gamma‐frequency stimulation: Implications for healthy ageing
    Parker Tichko, Ji Chul Kim, Edward W. Large, Psyche Loui · 2020 · European Journal of Neuroscience
  16. Serum apelin‐13 levels and total oxidant/antioxidant status of patients with Alzheimer’s disease
    Zeynep Yıldız, Nezaket Eren, Asuman Orçun, Fatma Münevver Gokyigit, Fatma Turgay, Lale Gündoğdu Çelebi · 2021 · Aging Medicine
  17. Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS‐HD study
    Xiaqing Jiang, Sid E. O’Bryant, Leigh Ann Johnson, Robert A. Rissman, Kristine S. Yaffe, The Health and Aging Brain Study (HABS‐HD) Study Team · 2023 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  18. Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia
    Nina Rostgaard, Gunhild Waldemar, Jørgen Erik Nielsen, Anja Hviid Simonsen · 2015 · Dementia and Geriatric Cognitive Disorders
  19. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF
    Lei Zheng, Xiangjun Kong, Yongjian Cui, Yan Wei, Jinrong Zhang, Wei Wei · 2016 · Neuroscience Letters
  20. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
    Myuri T. Ruthirakuhan, Nathan Herrmann, Ivonne Suridjan, Eleenor H Abraham, Ilan Farber, Krista L. Lanctôt · 2016 · Expert Opinion on Pharmacotherapy
  21. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort
    Sarah Westwood, Alison L. Baird, Sneha N. Anand, Alejo J. Nevado‐Holgado, Andrey Kormilitzin, Liu Shi, Abdul Hye, Nicholas James Ashton, Angharad R. Morgan, Isabelle Bos et al. · 2020 · Journal of Alzheimer s Disease
  22. Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer’s Disease: A Sign of Defective Proteostasis?
    Gianna Palmieri, Ennio Cocca, Marta Gogliettino, Roberta Valentino, Menotti Ruvo, Gloria Cristofano, Antonella Angiolillo, Marco Balestrieri, Mosé Rossi, Alfonso Di Costanzo · 2017 · Journal of Alzheimer s Disease
  23. Peripheral α-Defensins 1 and 2 are Elevated in Alzheimer's Disease
    Andrew D. Watt, Keyla A. Perez, Ching‐Seng Ang, Paul A. O’Donnell, Alan Rembach, Kelly Kathleen Pertile, Rebecca L. Rumble, Brett O. Trounson, Christopher James Fowler, Noel Garry Faux et al. · 2015 · Journal of Alzheimer s Disease
  24. Effect of human serum on the electrical detection of amyloid-β fibrils in biological environments using azo-dye immobilized field effect transistor (FET) biosensor
    Sho Hideshima, Shofarul Wustoni, Masumi Kobayashi, Hiroki Hayashi, Shigeki Kuroiwa, Takuya Nakanishi, Tetsuya Ōsaka · 2018 · Sensing and Bio-Sensing Research
  25. The impact of anorexigenic peptides in experimental models of Alzheimer’s disease pathology
    Lenka Maletı́nská, Andrea Popelová, Blanka Železná, Michal Bencze, Jaroslav Kuneš · 2018 · Journal of Endocrinology
  26. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient
    Jana Janssens, Sawal D. Atmosoerodjo, Yannick Vermeiren, Anthony Ray Absalom, Izaak den Daas, Peter Paul De Deyn · 2019 · Neurochemistry International
  27. Abnormal Platelet Amyloid-β Protein Precursor (AβPP) Metabolism in Alzheimer's Disease: Identification and Characterization of a New AβPP Isoform as Potential Biomarker
    Vesna Jelić, Göran Hagman, Natsuko Goto Yamamoto, Yasuhiro Teranishi, Takeshi Nishimura, Bengt G. Winblad, Pavel F. Pavlov · 2013 · Journal of Alzheimer s Disease
  28. Blood-based Alzheimer's disease diagnosis using fluorescent peptide nanoparticle arrays
    Sun, Leming, Lei, Yang, Wang, Yuerong, Liu, Dingchang · 2022 · Chinese Chemical Letters
  29. Remote data collection speech analysis and prediction of the identification of Alzheimer’s disease biomarkers in people at risk for Alzheimer’s disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol
    Sarah Gregory, Nicklas Linz, Alexandra König, Kai Langel, Hannah Pullen, Saturnino F. Luz, John Harrison, Craig William Ritchie · 2022 · BMJ Open
  30. A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer’s disease prediction
    Yi Zhang, Shasha Shen, Xiaokai Li, Songlin Wang, Z. Xiao, Jun Cheng, Ruifeng Li · 2023 · Neuroscience Letters
  31. ATP Binding Cassette Subfamily A Member 2 (ABCA2) Expression and Methylation are Associated with Alzheimer’s Disease
    Wanhua Hu, Xiaodong Lin, Huihe Zhang, Na Zhao · 2017 · Medical Science Monitor
  32. Alzheimer’s Disease Assessment: A Review and Illustrations Focusing on Item Response Theory Techniques
    Steve M. Balsis, Tabina K. Choudhury, Lisa D. Geraci, Jared F. Benge, Christopher J. Patrick · 2017 · Assessment
  33. APOE Gene polymorphism among Jordanian Alzheimer’s patients with relation to lipid profile
    Yanal A. Shafagoj, Randa G. Naffa, Mohammed S. El-Khateeb, Yazeed L. Abdulla, Aseem A. Al-qaddoumi, Faisal A. Khatib, Al‐Motassem Yousef, Eman M. Al-Khateeb · 2018 · Neurosciences
  34. Different techniques for Alzheimer’s disease classification using brain images: a study
    Ruhul Amin Hazarika, Ajith Abraham, Samarendra Nath Sur, Arnab Kumar Maji, Debdatta Kandar · 2021 · International Journal of Multimedia Information Retrieval
  35. Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
    Shiwali Sharma, T. Behl, Anoop Kumar, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, A. Al-Harrasi, S. Bungău · 2021 · BioMed Research International
  36. Artificial Intelligence Integration for Neurodegenerative Disorders
    Rajat Vashistha, Dinesh Yadav, Deepak Chhabra, Pratyoosh Shukla · 2018 · Elsevier eBooks
  37. T217-Phosphorylation Exacerbates Tau Pathologies and Tau-Induced Cognitive Impairment
    Xin Wang, Qian Rong Liu, Xiaoguang Li, Qiuzhi Zhou, Dongqin Wu, Shihong Li, Yanchao Liu, Jian‐Zhi Wang · 2021 · Journal of Alzheimer s Disease
  38. Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
    Silvia Boschi, Fausto Roveta, Alberto Grassini, Andrea Marcinnò, Aurora Cermelli, Fabio Ferrandes, Innocenzo Rainero, Elisa Rubino · 2022 · Brain Sciences
  39. Progress Towards a Consensus on Biomarkers for Alzheimer‘S Disease: A Review of Peripheral Analytes
    Alan Rembach, Tim M. Ryan, Blaine Russell Roberts, James D. Doecke, W.J. Wilson, Andrew D. Watt, Kevin Jeffrey Barnham, Colin Louis Masters · 2013 · Biomarkers in Medicine
  40. Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer’s Disease
    Ernest Dallé, Musa Vuyisile Mabandla, Willie M. U. Daniels · 2020 · Oxidative Medicine and Cellular Longevity
  41. Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease
    Sau Lai Lee, Philip Thomas, Michael Felix Fenech · 2015 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  42. Biosensors for the Determination of Amyloid-Beta Peptides and their Aggregates with Application to Alzheimer's Disease
    Yun Xing, Ning Xia · 2014 · Analytical Letters
  43. A Turkish 3-center study evaluation of serum folic acid and vitamin B12 levels in Alzheimer disease
    Nuriye Nuray Ulusu, Gökhan YILMAZ, Zübeyde Erbayraktar, Ahmet Turan EVLİCE, Sevgi Aras, Görsev Yener, Aslıhan Avcı · 2015 · TURKISH JOURNAL OF MEDICAL SCIENCES
  44. Therapy and diagnosis of Alzheimer's disease: from discrete metal complexes to metal–organic frameworks
    Amalia García-García, Sara Rojas, Antonio Rodríguez‐Diéguez · 2023 · Journal of Materials Chemistry B
  45. Neutral polymers as coatings for high resolution electrophoretic separation of Aβ peptides on glass microchips
    Kiarach Mesbah, Romain Verpillot, Marcella Chiari, Antoine Pallandre, Myriam Taverna · 2014 · The Analyst
  46. Bace1 Levels Are Increased in Plasma Of Alzheimer’S Disease Patients Compared with Matched Cognitively Healthy Controls
    Patrícia Regina Manzine, Matheus S. Souza, Márcia R. Cominetti · 2016 · Personalized Medicine
  47. Cofilin 2 in Serum as a Novel Biomarker for Alzheimer’s Disease in Han Chinese
    Yingni Sun, Lisheng Liang, Meili Dong, Cong Li, Zhenzhen Liu, Hongwei Gao · 2019 · Frontiers in Aging Neuroscience
  48. Carbon Nanostructure-Based Materials: A Novel Tool for Detection of Alzheimer’s Disease
    Mohammad Ashfaq, Neetu Talreja, Divya Chuahan, Werayut Srituravanich · 2019 · Springer eBooks
  49. High Sensitivity Cardiac Troponin T and Cognitive Function in the Oldest Old: The Leiden 85-Plus Study
    Bertens, Anne Suzanne, Sabayan, Behnam, de Craen, Anton J.M., Van der Mast, Roos C., Gussekloo, Jacobijn · 2017 · Journal of Alzheimer's Disease
  50. Effect of comorbid Parkinson’s disease and Parkinson’s disease dementia on the course of idiopathic normal pressure hydrocephalus
    Anri Sakurai, Taiji Tsunemi, Tomoyo Shimada, Kaito Kawamura, Madoka Nakajima, Masakazu Miyajima, Nobutaka Hattori · 2022 · Journal of neurosurgery
  51. Towards early diagnosis and screening of Alzheimer’s disease using frequency locked whispering gallery mode microtoroids
    Adley Nathanael Gin, Phuong-Diem Nguyen, Geidy E. Serrano, Gene E. Alexander, Judith Su · 2024 · npj Biosensing
  52. Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics
    Elsa El Abiad, Ali Al-Kuwari, Ubaida Al-Aani, Yaqoub Al Jaidah, Ali Châari · 2024 · Cells
  53. Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson's Disease Cases Lacking Alzheimer's Disease Pathology
    Chera L. Maarouf, Thomas G. Beach, Charles H. Adler, Michael H. Malek‐Ahmadi, Tyler A. Kokjohn, Brittany N. Dugger, Douglas G. Walker, Holly A. Shill, Sandra A. Jacobson, Marwan Noel Sabbagh et al. · 2013 · Biomarker Insights
  54. Comparing the Efficacy of Anodal, Cathodal, and Sham Transcranial Direct Current Stimulation on Brain-derived Neurotrophic Factor and Psychological Symptoms in Opioid-addicted Patients
    Zakaria Eskandari, Mohsen Dadashi, Hossein Mostafavi, Alireza Armani Kia, Reza Pirzeh · 2019 · Basic and Clinical Neuroscience Journal
  55. Micronucleus frequency in buccal mucosa cells of patients with neurodegenerative diseases
    Hauke Reimann, Helga Stopper, Thomas T. Polak, Martin Lauer, Martin J. Herrmann, Jürgen Deckert, Henning Hintzsche · 2020 · Scientific Reports
  56. 3.33 Conjugated Polymers for Biosensor Devices ☆
    Houwen Matthew Pan, Spandhana Gonuguntla, S. Li, Dieter Trau · 2016 · Elsevier eBooks
  57. Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer’s Disease
    Paloma Monllor, Esther Giraldo, Mari-Carmen Badía, José García de la Asunción, Maria-Dolores Alonso, Ana Lloret, José Viña · 2021 · Journal of Alzheimer s Disease
  58. Deficits in color detection in patients with Alzheimer disease
    Hee Jin Kim, Jae Hyun Ryou, Kang Ta Choi, Sun Mi Kim, Jee Taek Kim, Doug Hyun Han · 2022 · PLoS ONE
  59. Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders
    Sarita G. Singh, Sunil Kumar Gupta, Prahlad Kishore Seth · 2018 · Reviews in the Neurosciences
  60. Platelet dysfunction in hypercholesterolemia mice, two Alzheimer’s disease mouse models and in human patients with Alzheimer’s disease
    Barbara Plagg, Josef Marksteiner, Kathrin Maria Kniewallner, Christian Humpel · 2015 · Biogerontology
  61. A Rare Variation in the 3’ Untranslated Region of the Presenilin 2 Gene Is Linked to Alzheimer’s Disease
    Yana Pang, Tingting Li, Qi Wang, Wei Qin, Ying Li, Yiping Wei, Longfei Jia · 2021 · Molecular Neurobiology
  62. Censoring‐robust time‐dependent receiver operating characteristic curve estimators
    Michelle M. Nuño, Daniel L. Gillen · 2021 · Statistics in Medicine
  63. Novel techniques for early diagnosis and monitoring of Alzheimer’s disease
    Parul Parul, Animesh Kumar Singh, Shubha Shukla · 2024 · Expert Review of Neurotherapeutics
  64. A Review on Alzheimer Disease
    Kaloni Deeksha, Abhishek Negi · 2019 · International Journal of Neurodegenerative Disorders
  65. Gaussian Process-based prediction of memory performance and biomarker status in ageing and Alzheimer’s disease—A systematic model evaluation
    Aditya Nemali, Niklas Vockert, David Berron, Anne Maaß, José Bernal, Renat Yakupov, Oliver Peters, Daria Gref, Nicoleta Carmen Cosma, Lukas Preis et al. · 2023 · Medical Image Analysis
  66. Protein-Based Biomarkers in Cerebrospinal Fluid and Blood for Alzheimer’s Disease
    Yongyao Fu, Deming Zhao, Lifeng Yang · 2014 · Journal of Molecular Neuroscience
  67. Ultrabright fluorescent silica particles with a large number of complex spectra excited with a single wavelength for multiplex applications
    Shajesh Palantavida, B. Peng, Igor Yu. Sokolov · 2017 · Nanoscale
  68. Is Olfactory Epithelium Biopsy Useful for Confirming Alzheimer’s Disease?
    Maria Dantas Costa Lima Godoy, Marco Aurélio Fornazieri, Richard L. Doty, Fábio de Rezende Pinna, José Marcelo Farfel, Glaucia Bento dos Santos, Mariana Molina, Renata Eloah de Lucena Ferretti‐Rebustini, Renata Elaine Paraízo Leite, Cláudia Kimie Suemoto et al. · 2018 · Annals of Otology Rhinology & Laryngology
  69. Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study
    Alana C. Costa, Helena Passarelli Giroud Joaquim, Orestes Vicente Forlenza, Wagner F. Gattaz, Leda Leme Talib · 2019 · European Archives of Psychiatry and Clinical Neuroscience
  70. Co-Prevalence of Alzheimer’s Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis
    Eric J Schwaber, Atalie C. Thompson, Gordon Smilnak, Sandra S. Stinnett, Heather Elizabeth Whitson, Eleonora Maries Lad · 2020 · Journal of Alzheimer s Disease
  71. Impaired cortical oscillatory coupling in mild cognitive impairment: anatomical substrate and ApoE4 effects
    Gabriel González‐Escamilla, Mercedes Atienza, José Luis Cantero · 2014 · Brain Structure and Function
  72. PCA-assisted direct diagnosis of Aβ proteins for Alzheimer's disease using non-metallic SERS platform of graphitic carbon nitride@metal-organic framework
    Wenting Lan, Jialong Zhao, Xuesong Zhai, Chenjie Gu, Tao Jiang, Jianyong Wang · 2025 · Colloids and Surfaces B Biointerfaces
  73. Neuroprotective Potential of Raloxifene via G-Protein-Coupled Estrogen Receptors in Aβ-Oligomer-Induced Neuronal Injury
    Tetsuhito Nohara, Mayumi Tsuji, Tatsunori Oguchi, Yutaro Momma, Hideaki Ohashi, Miki Nagata, Naohito Ito, Ken Yamamoto, Hidetomo Murakami, Yuji Kiuchi · 2023 · Biomedicines
  74. Biomarkers of dementia: Comparison of electrochemiluminescence results and reference ranges with conventional ELISA
    Axel Regeniter, Jens Kühle, Thomas Baumann, Marc A. Sollberger, Marcus Herdener, Ursula Kunze, Michael C. Camuso, Andreas Urs Monsch · 2012 · Methods
  75. Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders
    Ashraf Ali, ISHFAQ AHMAD SHEIKH, Zeenat Mirza, Siew Hua Gan, Mohammad Amjad Kamal, Adel Mohammed Abuzenadah, Ghazi Damanhouri, Ghulam Md Ashraf · 2014 · Current Drug Metabolism
  76. The turn towards prevention – moral narratives and the vascularization of Alzheimer’s disease
    Annette Leibing · 2019 · New Genetics and Society
  77. Ultrahigh throughput beehive‐like device for blood plasma separation
    Fengtao Jiang, Nan Xiang, Zhonghua Ni · 2020 · Electrophoresis
  78. High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats
    Luke L. Liu, Xiaoli Shen, Huiying Gu, Gang Zhao, Yansheng Du, Wei Zheng · 2023 · Fluids and Barriers of the CNS
  79. Rare Variants and Transcriptomics in Alzheimer disease
    Crystal Humphries, Martin A. Kohli · 2014 · Current Genetic Medicine Reports
  80. End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease
    Alice Skoumalová, Pavla Mádlová, Eva Topinková · 2011 · Cell Biochemistry and Function
  81. Trans-Differentiation of Human Dental Pulp Stem Cells Into Cholinergic-Like Neurons Via Nerve Growth Factor
    Shahram Darabi, Taki Tiraihi, Maryam Nazm Bojnordi, Hatef Ghasemi Hamidabadi, Nourollah Rezaei, Maria Zahiri, Rafieh Alizadeh · 2019 · Basic and Clinical Neuroscience Journal
  82. Recent Progress in Electrochemical Detection of Beta-amyloid Peptides and Their Aggregates
    Ning Xia, Yong Keun Chang, Yuanqiang Hao · 2017 · International Journal of Electrochemical Science
  83. Surface plasmon resonance sensing of a biomarker of Alzheimer disease in an intensity measurement mode with a bimetallic chip
    Hyung Jin Kim, Young‐Soo Sohn, Chang-duk Kim, Daeho Jang · 2016 · Journal of the Korean Physical Society
  84. Rapid Recognition and Monitoring of Multiple Core Biomarkers with Point-of-Care Importance through Combinatorial DNA Logic Operation
    Yao Gao, Xue Wu Fan, Xuechen Zhang, Qing‐Lin Guan, Yong‐Heng Xing, Wenbo Song, Daqian Song · 2025 · Analytical Chemistry
  85. Isoelectric point region pI≈7.4 as a treasure island of abnormal proteoforms in blood
    Mohammad Pirmoradian, Dag Aarsland, Biomotif AB, Stockholm, Sweden, Roman A. Zubarev · 2016 · Discoveries
  86. Plasma amyloid β levels in Alzheimer’s disease and cognitively normal controls in Syrian population
    Rafah Manafikhi, M. Bassam Haik, Raghda Lahdo, Faizeh AlQuoubaili · 2021 · Medical Journal of the Islamic Republic of Iran
  87. Alzheimer’s Disease (AD): Risks, Treatments, Prevention, and Future Implementations
    Tanzeel Huma, Rukhsana Nawaz, Xiaohua Li, Andrew Willden · 2022 · Advances in Alzheimer s Disease
  88. The Clinical and Health Economic Value of Clinical Laboratory Diagnostics.
    Bruce W.M. Jordan, Cheryl Mitchell, Andy Anderson, Norbert Farkas, Richard Batrla · 2015 · PubMed Central
  89. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer’s disease
    Abhai Kumar, Smıta Sıngh, Ashish Kumar Verma, Vijaya Nath Mishra · 2018 · Neuroscience Letters
  90. Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy
    Bettina M. Foidl, Herbert Oberacher, Josef Marksteiner, Christian Humpel · 2020 · Frontiers in Neurology
  91. Biological Approach For Head Motion Detection And Analysis
    Alexandre Benoît, Alice Caplier · 2005 · INFM-OAR (INFN Catania)
  92. Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia
    André Karch, Franc Llorens, Matthias Schmitz, Amandeep Singh Arora, Saima Zafar, Peter Lange, Christian Schmidt, Inga Zerr · 2016 · Journal of Alzheimer s Disease
  93. Case Report: Usefulness of Biomarkers for Alzheimer's Disease in Two Cases With Very-Late-Onset Schizophrenia-Like Psychosis
    Yuto Satake, Hideki Kanemoto, Kenji Yoshiyama, Ryoko Nakahama, Keiko Matsunaga, Eku Shimosegawa, Takashi Morihara, Mamoru Hashimoto, Manabu Ikeda · 2021 · Frontiers in Psychiatry
  94. From Organotypic Mouse Brain Slices to Human Alzheimer’s Plasma Biomarkers: A Focus on Nerve Fiber Outgrowth
    Yilmaz, Sakir Necat, Steiner, Katharina, Marksteiner, Josef, Faserl, Klaus, Villunger, Mathias, Sarg, Bettina, Humpel, Christian · 2024 · Biomolecules
  95. Proteostasis and Neuroinflammation in Alzheimer’s Disease
    Augustina Potokiri, Hongmin Wang · 2025 · Journal of Integrative Neuroscience
  96. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer’s Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration
    Magnus Røgeberg, Ina S. Almdahl, Marianne Wettergreen, Lars N. G. Nilsson, Tormod Fladby · 2015 · Journal of Proteome Research
  97. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?
    Christian Humpel, Thomas Benke · 2017 · Pharmacology
  98. Highly Effective and Efficient Self-Assembled Multilayer-Based Electrode Passivation for Operationally Stable and Reproducible Electrolyte-Gated Transistor Biosensors
    Young-Min Song, Jong Yu Song, Jae-Eul Shim, Dong Hyung Kim, Hee‐Kyung Na, Eun‐Ah You, Young‐Geun Ha · 2023 · ACS Applied Materials & Interfaces
  99. Subacute cognitive deterioration with high serum anti‐thyroid peroxidase antibodies: two cases and a plea for pragmatism
    Kurt Segers, Philippe Braconnier, Francis Corazza, Luisa Divano, Asmaa Mabrouk, Jean Robberecht, Murielle Surquin · 2013 · Psychogeriatrics
  100. 21st Century Cures Act and similar policy efforts: at what cost?:
    Diana M. Zuckerman, Nicholas J. Jury, Christina Silcox · 2015 · BMJ